Literature DB >> 30246466

Reversible cerebral vasoconstriction syndrome in paediatric patients with systemic lupus erythematosus: implications for management.

Chloé Durrleman1, Olivier Naggara2,3,4, David Grevent3, Alexandre Belot5, Marie Desgranges6, Olivia Boyer4,7, Stéphane Chabrier8,9, Brigitte Bader-Meunier4,10, Manoelle Kossorotoff1,11.   

Abstract

Microvascular brain injury is well recognized in neuropsychiatric systemic lupus erythematosus (SLE), but cerebral large artery involvement is being debated. Three females with SLE, aged 9 to 14 years, had immunosuppressive treatment intensification because of lupus nephritis. Within the following days or weeks, they presented with intense cephalalgia - isolated or associated with neurological symptoms - and no or mild hypertension. Magnetic resonance angiography showed multiple stenoses within the circle of Willis. One patient had subsequent small subcortical cerebral infarction. Two patients were treated for neuropsychiatric SLE; one patient was treated for reversible cerebral vasoconstriction syndrome (RCVS). Angiography normalized within a few weeks in all three patients. Retrospectively, clinical and radiological features suggest that RCVS was the most likely diagnosis in all patients. Multidisciplinary analysis of clinical and angiographic features is recommended, as RCVS is rare in children and its recognition may help to adjust treatment. WHAT THIS PAPER ADDS: Reversible vasoconstriction syndrome was observed in paediatric systemic lupus erythematosus. Thorough imaging analysis was necessary to address this diagnosis in paediatric patients.
© 2018 Mac Keith Press.

Entities:  

Mesh:

Year:  2018        PMID: 30246466     DOI: 10.1111/dmcn.14031

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  2 in total

Review 1.  Childhood Cerebral Vasculitis : A Multidisciplinary Approach.

Authors:  Neetika Gupta; Shivaprakash B Hiremath; Richard I Aviv; Nagwa Wilson
Journal:  Clin Neuroradiol       Date:  2022-06-24       Impact factor: 3.156

Review 2.  Pathophysiology of reversible cerebral vasoconstriction syndrome.

Authors:  Shih-Pin Chen; Shuu-Jiun Wang
Journal:  J Biomed Sci       Date:  2022-09-21       Impact factor: 12.771

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.